George J. Morrow's most recent trade in Neurocrine Biosciences, Inc. was a trade of 3,318 Restricted Stock Unit done . Disclosure was reported to the exchange on May 21, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Neurocrine Biosciences, Inc. | George J. Morrow | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2025 | 3,318 | 3,318 | - | - | Restricted Stock Unit | |
| Neurocrine Biosciences, Inc. | George J. Morrow | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 May 2025 | 2,869 | 0 | - | - | Restricted Stock Unit | |
| Neurocrine Biosciences, Inc. | George J. Morrow | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 May 2025 | 2,869 | 7,068 (0%) | 0% | 0 | Common Stock | |
| Align Tech | George J. Morrow | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2025 | 1,745 | 1,745 | - | - | Restricted Stock Units | |
| Align Tech | George J. Morrow | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 May 2025 | 1,148 | 0 | - | - | Restricted Stock Units | |
| Align Tech | George J. Morrow | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 May 2025 | 1,148 | 3,291 (0%) | 0% | 0 | Common Stock | |
| Neurocrine Biosciences, Inc. | George J. Morrow | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 May 2024 | 2,869 | 2,869 | - | - | Restricted Stock Unit | |
| Align Tech | George J. Morrow | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 May 2024 | 1,148 | 1,148 | - | - | Restricted Stock Units | |
| Neurocrine Biosciences, Inc. | George J. Morrow | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 May 2024 | 4,199 | 4,199 (0%) | 0% | 0 | Common Stock | |
| Neurocrine Biosciences, Inc. | George J. Morrow | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 May 2024 | 4,199 | 0 | - | - | Restricted Stock Unit | |
| Align Tech | George J. Morrow | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 May 2024 | 1,029 | 0 | - | - | Restricted Stock Units | |
| Align Tech | George J. Morrow | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 May 2024 | 1,029 | 2,143 (0%) | 0% | 0 | Common Stock | |
| Neurocrine Biosciences, Inc. | George J. Morrow | Director | Sale of securities on an exchange or to another person at price $ 139.41 per share. | 14 Mar 2024 | 20,000 | 0 (0%) | 0% | 139.4 | 2,788,278 | Common Stock |
| Neurocrine Biosciences, Inc. | George J. Morrow | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 39.79 per share. | 14 Mar 2024 | 20,000 | 20,000 (0%) | 0% | 39.8 | 795,800 | Common Stock |
| Neurocrine Biosciences, Inc. | George J. Morrow | Director | Sale of securities on an exchange or to another person at price $ 139.42 per share. | 14 Mar 2024 | 20,000 | 0 (0%) | 0% | 139.4 | 2,788,432 | Common Stock |
| Neurocrine Biosciences, Inc. | George J. Morrow | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 39.79 per share. | 14 Mar 2024 | 20,000 | 20,000 (0%) | 0% | 39.8 | 795,800 | Common Stock |
| Neurocrine Biosciences, Inc. | George J. Morrow | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Mar 2024 | 20,000 | 0 | - | - | Non-Qualified Stock Option | |
| Neurocrine Biosciences, Inc. | George J. Morrow | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Mar 2024 | 20,000 | 20,000 | - | - | Non-Qualified Stock Option | |
| Align Tech | George J. Morrow | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 30 May 2023 | 10,000 | 3,273 (0%) | 0% | 0 | Common Stock | |
| Neurocrine Biosciences, Inc. | George J. Morrow | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 May 2023 | 4,199 | 4,199 | - | - | Restricted Stock Unit | |
| Align Tech | George J. Morrow | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 May 2023 | 1,114 | 0 | - | - | Restricted Stock Unit | |
| Align Tech | George J. Morrow | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 May 2023 | 1,114 | 1,114 (0%) | 0% | 0 | Common Stock | |
| Align Tech | George J. Morrow | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 May 2023 | 1,029 | 1,029 | - | - | Restricted Stock Units | |
| Neurocrine Biosciences, Inc. | George J. Morrow | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2022 | 9,724 | 9,724 | - | - | Non-Qualified Stock Option | |
| Align Tech | George J. Morrow | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2022 | 1,114 | 1,114 | - | - | Restricted Stock Units | |
| Align Tech | George J. Morrow | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 May 2022 | 524 | 13,273 (0%) | 0% | 0 | Common Stock | |
| Align Tech | George J. Morrow | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 May 2022 | 524 | 0 | - | - | Restricted Stock Units | |
| Align Tech | George J. Morrow | Director | Sale of securities on an exchange or to another person at price $ 707.95 per share. | 02 Aug 2021 | 3,248 | 13,001 (0%) | 0% | 708.0 | 2,299,422 | Common Stock |
| Align Tech | George J. Morrow | Director | Sale of securities on an exchange or to another person at price $ 705.74 per share. | 02 Aug 2021 | 1,500 | 16,249 (0%) | 0% | 705.7 | 1,058,610 | Common Stock |
| Align Tech | George J. Morrow | Director | Sale of securities on an exchange or to another person at price $ 708.93 per share. | 02 Aug 2021 | 252 | 12,749 (0%) | 0% | 708.9 | 178,651 | Common Stock |
| Neurocrine Biosciences, Inc. | George J. Morrow | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 May 2021 | 8,833 | 8,833 | - | - | Non-Qualified Stock Option | |
| Align Tech | George J. Morrow | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 May 2021 | 1,271 | 17,749 (0%) | 0% | 0 | Common Stock | |
| Align Tech | George J. Morrow | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 May 2021 | 1,271 | 0 | - | - | Restricted Stock Unit | |
| Align Tech | George J. Morrow | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 May 2021 | 524 | 524 | - | - | Restricted Stock Unit | |
| Align Tech | George J. Morrow | Director | Sale of securities on an exchange or to another person at price $ 622.19 per share. | 08 Feb 2021 | 4,798 | 26,680 (0%) | 0% | 622.2 | 2,985,268 | Common Stock |
| Align Tech | George J. Morrow | Director | Sale of securities on an exchange or to another person at price $ 625.02 per share. | 08 Feb 2021 | 3,657 | 21,415 (0%) | 0% | 625.0 | 2,285,698 | Common Stock |
| Align Tech | George J. Morrow | Director | Sale of securities on an exchange or to another person at price $ 626.71 per share. | 08 Feb 2021 | 3,337 | 18,078 (0%) | 0% | 626.7 | 2,091,331 | Common Stock |
| Align Tech | George J. Morrow | Director | Sale of securities on an exchange or to another person at price $ 627.46 per share. | 08 Feb 2021 | 1,121 | 16,957 (0%) | 0% | 627.5 | 703,383 | Common Stock |
| Align Tech | George J. Morrow | Director | Sale of securities on an exchange or to another person at price $ 622.98 per share. | 08 Feb 2021 | 1,101 | 25,579 (0%) | 0% | 623.0 | 685,901 | Common Stock |
| Align Tech | George J. Morrow | Director | Sale of securities on an exchange or to another person at price $ 623.92 per share. | 08 Feb 2021 | 507 | 25,072 (0%) | 0% | 623.9 | 316,327 | Common Stock |
| Align Tech | George J. Morrow | Director | Sale of securities on an exchange or to another person at price $ 628.52 per share. | 08 Feb 2021 | 479 | 16,478 (0%) | 0% | 628.5 | 301,061 | Common Stock |
| Align Tech | George J. Morrow | Director | Sale of securities on an exchange or to another person at price $ 480.03 per share. | 04 Nov 2020 | 5,000 | 31,478 (0%) | 0% | 480.0 | 2,400,162 | Common Stock |
| Align Tech | George J. Morrow | Director | Sale of securities on an exchange or to another person at price $ 466.85 per share. | 26 Oct 2020 | 10,983 | 39,205 (0%) | 0% | 466.9 | 5,127,434 | Common Stock |
| Align Tech | George J. Morrow | Director | Sale of securities on an exchange or to another person at price $ 464.43 per share. | 26 Oct 2020 | 4,805 | 50,188 (0%) | 0% | 464.4 | 2,231,563 | Common Stock |
| Align Tech | George J. Morrow | Director | Sale of securities on an exchange or to another person at price $ 468.78 per share. | 26 Oct 2020 | 2,727 | 36,478 (0%) | 0% | 468.8 | 1,278,367 | Common Stock |
| Align Tech | George J. Morrow | Director | Sale of securities on an exchange or to another person at price $ 460.39 per share. | 26 Oct 2020 | 1,485 | 54,993 (0%) | 0% | 460.4 | 683,674 | Common Stock |